Related Products
Hepatocarcinoma, 20 cases. Tumor and matched NAT.
131
$1,043.00
Hepatocarcinoma, 20 cases. Tumor and matched NAT.
131-HLiv-D051Bch-01-GEN
Colon adenocarcinoma, 75 cases. Tumor and matched NAT.
131
$1,911.00
Colon adenocarcinoma, 75 cases. Tumor and matched NAT.
131-HColA150CS02-GEN
Rectum adenocarcinoma (90 cases), tumor and matched NAT.
131
$4,931.50
Rectum adenocarcinoma (90 cases), tumor and matched NAT.
131-HRec-Ade180Sur-05-GEN
Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT.
131
$5,484.50
Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT.
131-HPan-Ade170Sur-01-GEN
Lung carcinoma,92 cases, tumor and matched NAT.
131
$5,484.50
Lung carcinoma,92 cases, tumor and matched NAT.
131-HLugA180Su03-GEN
Hepatocellular carcinoma, 30 cases. Tumor and matched NAT.
131
$1,361.50
Hepatocellular carcinoma, 30 cases. Tumor and matched NAT.
131-HLivH090PG01-GEN
Lung adenocarcinoma, 75 cases, tumor and matched NAT.
131
$1,879.50
Lung adenocarcinoma, 75 cases, tumor and matched NAT.
131-HLugA150CS02-GEN
Hepatocellular carcinoma, 75 cases. Tumor and matched NAT.
131
$2,156.00
Hepatocellular carcinoma, 75 cases. Tumor and matched NAT.
131-HLivH160CS01-GEN